Warning: fopen(/home/virtual/colon/journal/upload/ip_log/ip_log_2025-02.txt): failed to open stream: Permission denied in /home/virtual/lib/view_data.php on line 95 Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 96
Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
© 2012 The Korean Society of Coloproctology
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Values are presented as number (%).
FL, fluorouracil/leucovorin; CEA, careinoembryonal antigen; LN, lymph nodes; LD, low-grade differentiation; HD, high-grade differentiation.
aFL regimen was combination chemotherapy of infusional 5-fluorouracil (5-FU) and leucovorin. bFOLFOX regimen was modified FOLFOX6 regimen comprising of a combination of oxaliplatin and infusional 5-FU/Leucovorin. cRight colon was defined from the cecum to the transverse colon; left colon was defined from the splenic flexure to the rectosigmoid junction. dLow-grade differentiation was defined as moderately- to well-differentiated carcinoma; high-grade differentiation was defined as undifferentiated to poorly-differentiated carcinoma.
OS, overall survival; DFS, disease-free survival; CEA, careinoembryonal antigen; LN, lymph nodes; LD, low-grade differentiation; HD, high-grade differentiation; FL, fluorouracil/leucovorin.
aRight colon was defined from the cecum to the transverse colon; left colon was defined from the splenic flexure to the rectosigmoid junction. bLow-grade differentiation was defined as moderately- to well-differentiated carcinoma; high-grade differentiation was defined as undifferentiated to poorly-differentiated carcinoma. cFL regimen was combination chemotherapy of infusional 5-fluorouracil (5-FU) and leucovorin. dFOLFOX regimen was modified FOLFOX6 regimen comprising of combination of oxaliplatin and infusional 5-FU/Leucovorin.
Comparison of the clinicopathologic characteristics between the FL/capecitabine patient group and the FOLFOX patient group (%)
Values are presented as number (%).
FL, fluorouracil/leucovorin; CEA, careinoembryonal antigen; LN, lymph nodes; LD, low-grade differentiation; HD, high-grade differentiation.
aFL regimen was combination chemotherapy of infusional 5-fluorouracil (5-FU) and leucovorin. bFOLFOX regimen was modified FOLFOX6 regimen comprising of a combination of oxaliplatin and infusional 5-FU/Leucovorin. cRight colon was defined from the cecum to the transverse colon; left colon was defined from the splenic flexure to the rectosigmoid junction. dLow-grade differentiation was defined as moderately- to well-differentiated carcinoma; high-grade differentiation was defined as undifferentiated to poorly-differentiated carcinoma.
Estimated survival rates according to the clinicopathologic variables and chemotherapeutic regimens
OS, overall survival; DFS, disease-free survival; CEA, careinoembryonal antigen; LN, lymph nodes; LD, low-grade differentiation; HD, high-grade differentiation; FL, fluorouracil/leucovorin.
aRight colon was defined from the cecum to the transverse colon; left colon was defined from the splenic flexure to the rectosigmoid junction. bLow-grade differentiation was defined as moderately- to well-differentiated carcinoma; high-grade differentiation was defined as undifferentiated to poorly-differentiated carcinoma. cFL regimen was combination chemotherapy of infusional 5-fluorouracil (5-FU) and leucovorin. dFOLFOX regimen was modified FOLFOX6 regimen comprising of combination of oxaliplatin and infusional 5-FU/Leucovorin.
Values are presented as number (%). FL, fluorouracil/leucovorin; CEA, careinoembryonal antigen; LN, lymph nodes; LD, low-grade differentiation; HD, high-grade differentiation. aFL regimen was combination chemotherapy of infusional 5-fluorouracil (5-FU) and leucovorin. bFOLFOX regimen was modified FOLFOX6 regimen comprising of a combination of oxaliplatin and infusional 5-FU/Leucovorin. cRight colon was defined from the cecum to the transverse colon; left colon was defined from the splenic flexure to the rectosigmoid junction. dLow-grade differentiation was defined as moderately- to well-differentiated carcinoma; high-grade differentiation was defined as undifferentiated to poorly-differentiated carcinoma.
OS, overall survival; DFS, disease-free survival; CEA, careinoembryonal antigen; LN, lymph nodes; LD, low-grade differentiation; HD, high-grade differentiation; FL, fluorouracil/leucovorin. aRight colon was defined from the cecum to the transverse colon; left colon was defined from the splenic flexure to the rectosigmoid junction. bLow-grade differentiation was defined as moderately- to well-differentiated carcinoma; high-grade differentiation was defined as undifferentiated to poorly-differentiated carcinoma. cFL regimen was combination chemotherapy of infusional 5-fluorouracil (5-FU) and leucovorin. dFOLFOX regimen was modified FOLFOX6 regimen comprising of combination of oxaliplatin and infusional 5-FU/Leucovorin.